Phibro Animal Health Corp (PAHC)
13.09
+0.25
(+1.95%)
USD |
NASDAQ |
Mar 27, 16:00
Phibro Animal Health Revenue (TTM): 982.01M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 982.01M |
September 30, 2023 | 976.72M |
June 30, 2023 | 977.89M |
March 31, 2023 | 978.10M |
December 31, 2022 | 972.05M |
September 30, 2022 | 960.12M |
June 30, 2022 | 942.26M |
March 31, 2022 | 907.27M |
December 31, 2021 | 879.38M |
September 30, 2021 | 852.82M |
June 30, 2021 | 833.35M |
March 31, 2021 | 798.96M |
December 31, 2020 | 797.96M |
September 30, 2020 | 805.83M |
June 30, 2020 | 800.35M |
March 31, 2020 | 818.35M |
December 31, 2019 | 813.35M |
September 30, 2019 | 817.56M |
June 30, 2019 | 828.00M |
March 31, 2019 | 835.90M |
December 31, 2018 | 839.07M |
Date | Value |
---|---|
September 30, 2018 | 826.72M |
June 30, 2018 | 819.98M |
March 31, 2018 | 803.03M |
December 31, 2017 | 783.98M |
September 30, 2017 | 769.71M |
June 30, 2017 | 764.28M |
March 31, 2017 | 758.62M |
December 31, 2016 | 752.22M |
September 30, 2016 | 752.39M |
June 30, 2016 | 751.53M |
March 31, 2016 | 747.30M |
December 31, 2015 | 751.34M |
September 30, 2015 | 748.25M |
June 30, 2015 | 748.59M |
March 31, 2015 | 747.32M |
December 31, 2014 | 733.09M |
September 30, 2014 | 717.14M |
June 30, 2014 | 691.91M |
March 31, 2014 | 672.44M |
December 31, 2013 | 661.86M |
September 30, 2013 | 653.27M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
797.96M
Minimum
Dec 2020
982.01M
Maximum
Dec 2023
878.91M
Average
844.36M
Median
Revenue (TTM) Benchmarks
Stryker Corp | 20.50B |
Boston Scientific Corp | 14.24B |
Steris PLC | 5.407B |
Envista Holdings Corp | 2.566B |
Perspective Therapeutics Inc | 6.956M |